uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Surfaxin
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/000625
ATC code
-
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Not specified
MeSH:
Respiratory Distress Syndrome, Newborn
Active substances
sinapultide
Dipalmitoylphosphatidylcholine
palmitoyl-oleoyl phosphatidylglycerol
palmitic acid
Marketing Authorisation Holder
Pharm Research Associates (UK) Limited
MAH
Surfaxin | uMedical